Updated:
Cooper University Health Care System
Cooper University Health Care traces its roots to 1887 as a small hospital serving Camden's industrial workers. Today it operates as a non-profit academic...
Cooper University Health Care System
Cooper University Health Care traces its roots to 1887 as a small hospital serving Camden's industrial workers. Today it operates as a non-profit academic medical center and the principal clinical partner of Cooper Medical School of Rowan University. George E. Norcross III, a defining figure in New Jersey politics and insurance, has chaired the board for over three decades, alongside co-CEOs Kevin O'Dowd and Anthony Mazzarelli, who split administrative and clinical leadership. The wealth underlying Cooper is operational revenue — patient care, state support, philanthropy — not a family fortune converted into an investment vehicle. Cooper deploys capital almost exclusively into its own physical and clinical infrastructure. Its portfolio spans a flagship 635-bed quaternary-care campus in Camden, a growing ambulatory network across southern New Jersey, specialty-care hubs in Moorestown and Cherry Hill, and a recent merger with Cape Regional Health System completed in 2024. The system has committed $2 billion to a Camden campus expansion, adding 100+ inpatient beds and modernizing surgical facilities. Unlike a traditional asset owner, Cooper's 'deployment' is measured in square-footage, service-line launches, and JV equity — including a cancer partnership with MD Anderson Cancer Center and a cardiac and neuroscience joint venture with Inspira Health. Cooper's scale reflects the consolidation economics of non-profit healthcare. It employs over 9,000 people across 100+ ambulatory locations, generating annual operating revenue exceeding $2 billion (per public record). The system raised over $30 million in its most recent philanthropic campaign through The Cooper Foundation, which funds capital projects and patient programs. In May 2024, Cooper completed its merger with Cape Regional Health System, adding an acute-care hospital in Cape May Court House and extending its geographic reach into southern coastal New Jersey, further entrenching its regional market dominance. What distinguishes Cooper structurally is its role as the quasi-public health anchor for a historically disinvested city. The board, led by Norcross, operates with an unusual blend of political connectivity, real-estate development ambition, and clinical delivery — a hybrid governance model that makes Cooper less a typical non-profit endowment and more a vertically integrated healthcare-and-redevelopment enterprise in one of America's poorest urban corridors.
General information
Firm type
Endowment / Foundation
Year founded
1887
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Camden
Corporate office
Camden, NJ, United States
Principals
George E. Norcross III
Chairman of the Board of Trustees
Kevin M. O'Dowd
Co-Chief Executive Officer
Anthony J. Mazzarelli
Co-Chief Executive Officer
Sector focus
Frequently asked questions
Is Cooper University Health Care structured as an endowed foundation or an operating healthcare system?
Cooper is an operating non-profit academic medical center, not a typical endowed foundation. Its investment posture is reinvesting operating surpluses and philanthropy into physical infrastructure, clinical programs, and joint ventures rather than managing a diversified portfolio of third-party fund commitments. The $2 billion Camden campus expansion exemplifies this capital-allocation model.
How does George Norcross's role as board chair influence Cooper's investment decisions?
George E. Norcross III has served as chairman for over three decades and shapes the system's strategy through the board of trustees, blending healthcare expansion with broader Camden redevelopment. His influence extends into real-estate site selection, political capital for state approvals, and governance appointments. The board structure places ultimate fiduciary and strategic authority under his chairmanship, with day-to-day operations run by the co-CEOs.
What is Cooper's relationship with Rowan University and MD Anderson Cancer Center?
Cooper is the founding clinical partner of Cooper Medical School of Rowan University, opened in 2012 — South Jersey's only four-year medical school. Separately, Cooper is a certified member of MD Anderson Cancer Network, providing South Jersey patients access to MD Anderson protocols and clinical trials without traveling to Houston. Both partnerships are operational joint ventures, not passive financial investments.
Does Cooper maintain a purely philanthropic foundation separate from its operating entity?
Yes. The Cooper Foundation is a separate 501(c)(3) that raises philanthropic gifts to fund capital projects, patient care programs, clinical research, and education at Cooper University Health Care. It raised over $30 million in its most recent campaign and operates under independent governance, though the foundation's mission is entirely directed at supporting the health system.
What is Cooper's geographic footprint and market concentration?
Cooper's primary market is southern New Jersey, anchored by its Camden flagship campus and extending through over 100 ambulatory locations across the region. The May 2024 merger with Cape Regional Health System expanded its reach into Cape May County. Cooper does not currently operate hospitals outside New Jersey, making it a concentrated regional health system rather than a multi-state platform.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: